190 related articles for article (PubMed ID: 16206288)
21. Immunohistochemical analysis of chromogranin A and p53 expressions in ulcerative colitis-associated neoplasia: neuroendocrine differentiation as an early event in the colitis-neoplasia sequence.
Shigaki K; Mitomi H; Fujimori T; Ichikawa K; Tomita S; Imura J; Fujii S; Itabashi M; Kameoka S; Sahara R; Takenoshita S
Hum Pathol; 2013 Nov; 44(11):2393-9. PubMed ID: 24029705
[TBL] [Abstract][Full Text] [Related]
22. p53 Expression as a Diagnostic Biomarker in Ulcerative Colitis-Associated Cancer.
Kobayashi K; Tomita H; Shimizu M; Tanaka T; Suzui N; Miyazaki T; Hara A
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28621756
[TBL] [Abstract][Full Text] [Related]
23. p53R2 inhibits the proliferation of human cancer cells in association with cell-cycle arrest.
Zhang K; Wu J; Wu X; Wang X; Wang Y; Zhou N; Kuo ML; Liu X; Zhou B; Chang L; Ann D; Yen Y
Mol Cancer Ther; 2011 Feb; 10(2):269-78. PubMed ID: 21216934
[TBL] [Abstract][Full Text] [Related]
24. p53R2 regulates thioredoxin reductase activity through interaction with TrxR2.
Park SJ; Kim HB; Piao C; Kang MY; Park SG; Kim SW; Lee JH
Biochem Biophys Res Commun; 2017 Jan; 482(4):706-712. PubMed ID: 27866984
[TBL] [Abstract][Full Text] [Related]
25. Transcription pattern of p53-targeted DNA repair genes in the hypoxia-tolerant subterranean mole rat Spalax.
Shams I; Malik A; Manov I; Joel A; Band M; Avivi A
J Mol Biol; 2013 Apr; 425(7):1111-8. PubMed ID: 23318952
[TBL] [Abstract][Full Text] [Related]
26. Effect of siRNA-mediated silencing of p53R2 gene on sensitivity of T-ALL cellsto Daunorubicin.
Kiani Ghalesardi O; Zaker F; Ghotaslou A; Boustani H; Rezvani MR; Kiani J; Shahidi M
Gene; 2023 Sep; 880():147622. PubMed ID: 37419428
[TBL] [Abstract][Full Text] [Related]
27. Wild-type p53 regulates human ribonucleotide reductase by protein-protein interaction with p53R2 as well as hRRM2 subunits.
Xue L; Zhou B; Liu X; Qiu W; Jin Z; Yen Y
Cancer Res; 2003 Mar; 63(5):980-6. PubMed ID: 12615712
[TBL] [Abstract][Full Text] [Related]
28. Ribonucleotide reductase small subunit p53R2 facilitates p21 induction of G1 arrest under UV irradiation.
Xue L; Zhou B; Liu X; Heung Y; Chau J; Chu E; Li S; Jiang C; Un F; Yen Y
Cancer Res; 2007 Jan; 67(1):16-21. PubMed ID: 17210678
[TBL] [Abstract][Full Text] [Related]
29. Infrequent alteration in the p53R2 gene in human transitional cell carcinoma of the urinary tract.
Hayashi H; Furihata M; Kuwahara M; Kagawa S; Shuin T; Ohtsuki Y
Pathobiology; 2004; 71(2):103-6. PubMed ID: 14707445
[TBL] [Abstract][Full Text] [Related]
30. p53 immunohistochemistry of ulcerative colitis-associated with dysplasia and carcinoma.
Sato A; MacHinami R
Pathol Int; 1999 Oct; 49(10):858-68. PubMed ID: 10571818
[TBL] [Abstract][Full Text] [Related]
31. Ribonucleotide reductase small subunit p53R2 promotes oral cancer invasion via the E-cadherin/beta-catenin pathway.
Yanamoto S; Kawasaki G; Yamada S; Yoshitomi I; Yoshida H; Mizuno A
Oral Oncol; 2009 Jun; 45(6):521-5. PubMed ID: 18804405
[TBL] [Abstract][Full Text] [Related]
32. Effect of high-risk human papillomavirus oncoproteins on p53R2 gene expression after DNA damage.
Lembo D; Donalisio M; Cornaglia M; Azzimonti B; Demurtas A; Landolfo S
Virus Res; 2006 Dec; 122(1-2):189-93. PubMed ID: 16872707
[TBL] [Abstract][Full Text] [Related]
33. MEK2 regulates ribonucleotide reductase activity through functional interaction with ribonucleotide reductase small subunit p53R2.
Piao C; Youn CK; Jin M; Yoon SP; Chang IY; Lee JH; You HJ
Cell Cycle; 2012 Sep; 11(17):3237-49. PubMed ID: 22895183
[TBL] [Abstract][Full Text] [Related]
34. Akt and p53R2, partners that dictate the progression and invasiveness of cancer.
Yousefi B; Samadi N; Ahmadi Y
DNA Repair (Amst); 2014 Oct; 22():24-9. PubMed ID: 25086499
[TBL] [Abstract][Full Text] [Related]
35. Significant correlation of morphological remodeling in ulcerative colitis with disease duration and between elevated p53 and p21 expression in rectal mucosa and neoplastic development.
Mitsuhashi J; Mikami T; Saigenji K; Okayasu I
Pathol Int; 2005 Mar; 55(3):113-21. PubMed ID: 15743319
[TBL] [Abstract][Full Text] [Related]
36. Expression of activation-induced cytidine deaminase in ulcerative colitis-associated carcinogenesis.
Gushima M; Hirahashi M; Matsumoto T; Fujita K; Ohuchida K; Oda Y; Yao T; Iida M; Tsuneyoshi M
Histopathology; 2011 Sep; 59(3):460-9. PubMed ID: 22034886
[TBL] [Abstract][Full Text] [Related]
37. Down-regulation of Fer induces ROS levels accompanied by ATM and p53 activation in colon carcinoma cells.
Makovski A; Yaffe E; Shpungin S; Nir U
Cell Signal; 2012 Jul; 24(7):1369-74. PubMed ID: 22434045
[TBL] [Abstract][Full Text] [Related]
38. P53R2, p53 inducible ribonucleotide reductase gene, correlated with tumor progression of non-small cell lung cancer.
Uramoto H; Sugio K; Oyama T; Hanagiri T; Yasumoto K
Anticancer Res; 2006; 26(2A):983-8. PubMed ID: 16619496
[TBL] [Abstract][Full Text] [Related]
39. DNA damage-induced expression of p53 suppresses mitotic checkpoint kinase hMps1: the lack of this suppression in p53MUT cells contributes to apoptosis.
Bhonde MR; Hanski ML; Budczies J; Cao M; Gillissen B; Moorthy D; Simonetta F; ScherĂ¼bl H; Truss M; Hagemeier C; Mewes HW; Daniel PT; Zeitz M; Hanski C
J Biol Chem; 2006 Mar; 281(13):8675-85. PubMed ID: 16446370
[TBL] [Abstract][Full Text] [Related]
40. Novel regulators and molecular mechanisms of p53R2 and its disease relevance.
Cho EC; Yen Y
Biochimie; 2016 Apr; 123():81-4. PubMed ID: 26796884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]